Dr Pierre COLIN est conventionné secteur 2 et est signataire du CAS (Contrat d'Accès aux Soins).
En étant signataire du CAS, ce praticien s'engage à modérer ses dépassements d'honoraires.
En contrepartie, l'Assurance Maladie offre une meilleure prise en charge pour les patients.

Dr Pierre COLIN accepte la carte vitale pour ses consultations.

Les types d'actes proposés par Dr Pierre COLIN sont :

• Pose de sonde ou d'endoprothèse des voies urinaires
• Chirurgie de l'urètre (voie urinaire entre la vessie et l'extérieur)
• Chirurgie de l'uretère (voies urinaires entre le rein et la vessie)
• Chirurgie de la prostate
• Chirurgie du pénis
• Chirurgie de la vessie
• Endoscopie de l'appareil urinaire
• Chirurgie des organes génitaux masculins (hors pénis et prostate)
• Fixation du vagin (prolapsus...)
• Traitement des calculs du rein et des voies urinaires
• Exploration fonctionnelle de l'appareil urinaire
• Instillation de médicament dans la vessie

Dr Pierre COLIN exerce aux adresses suivantes :

• 69 Rue De La Louviere, 59042 Lille
• 20 Rue Des Vicaires, 59000 Lille

Moyens de transports (métro et bus) à proximité du lieu d'exercice de Dr Pierre COLIN :

• Ballon (Arrêt de bus)
• Dieu De Marcq (Arrêt de bus)
• Saint Maurice Pellevoisin (Station de métro - Ligne 2)
• Gassendi (Arrêt de bus)
• St Maurice Pellevoisin (Arrêt de bus)
• Caulier (Station de métro - Ligne 1)

Dr Pierre COLIN accepte les chèques, les espèces et la carte bancaire.

Dr Pierre COLIN pratique le Tiers Payant avec la Sécurité Sociale.

Dr Pierre COLIN est ouvert aux consultation aux créneaux horaires suivants :

• Lundi 08:30-12:30, 13:30-18:00
• Mardi 08:30-12:30, 13:30-18:00
• Mercredi 08:30-12:30, 13:30-18:00
• Jeudi 08:30-12:30, 13:30-18:00
• Vendredi 08:30-12:30, 13:30-17:00

Formations de Dr Pierre COLIN :

2010
D.E.S. Chirurgie générale - Faculté de médecine Henri-Warembourg de Lille


2012
Thèse de docteur en sciences (option cancérologie) - Université Lille Nord de France

2011
D.E.S.C.Q. chirurgie urologique - Faculté de médecine Henri-Warembourg de Lille

2009
Thèse de docteur en médecine - Faculté de médecine Henri-Warembourg de Lille

2009
Master 2 de sciences chirurgicales - Université Paris 12 - Créteil.

Ses expériences professionnelles sont les suivantes :

Depuis 2013
Cabinet - Lille

Depuis 2013
Praticien - Hôpital Privé de La Louvière - Lille - Urologie

2013 - 2014
Praticien attaché - CH Seclin - Seclin - Urologie

2012 - 2013
Praticien hospitalier - CH Seclin - Seclin - Urologie

2010 - 2012
Chef de clinique en région - CHRU Lille/CH Seclin - Lille/Seclin - Urologie

2004 - 2010
Interne.

Dr Pierre COLIN est membre des associations suivantes :

Membre - Association Française d’Urologie (AFU).

Les publications scientifiques de Dr Pierre COLIN sont les suivantes :

2015
Risk-adapted strategy for the kidney-sparing management of upper tract tumours - Seisen T, Colin P, Rouprêt M Nat Rev Urol

2015
Follow-up of urothelial carcinoma: Review of the Cancer Committee of the French Association of Urology - Colin P, Neuzillet Y, Pignot G, Rouprêt M, Comperat E, Larré S, Roy C, Quintens H, Houedé N, Soulié M, Pfister C; les membres du Comité de cancérologie de l’Association française d’urologie. Prog Urol.

2015
A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma - Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R, Compérat E, Mozer P, Cussenot O, Shariat SF, Rouprêt M. Eur Urol

2014
Urothelial carcinomas of the upper tract: the myth became a reality - Rouprêt M, Colin P. Prog Urol.

2014
Surgical treatment of upper tract urothelial carcinomas by nephroureterectomy: state of the art for the yearly scientific report of the French National Association of Urology - Neuzillet Y, Colin P, Phé V, Shariat SF, Rouprêt M Prog Urol.

2014
Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies - Yakoubi R, Colin P, Seisen T, Léon P, Nison L, Bozzini G, Shariat SF, Rouprêt M Eur J Surg Oncol

2014
Prognostic factors of upper tract urothelial carcinomas and impact on survival: a systematic review for the yearly scientific report of the French National Association of Urology - Colin P, Irani J, Drouin SJ, Shariat SF, Rouprêt M. Prog Urol.

2014
Post-operative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localized and/or locally advanced upper tract urothelial carcinoma without metastasis. - Seisen T, Colin P, Hupertan V, Yates DR, Xylinas E, Nison L, Cussenot O, Neuzillet Y, Bensalah K, Novara G, Montorsi F, Zigeuner R, Remzi M, Shariat SF, Rouprêt M BJU Int.

2014
Pathologic analysis of upper tract urothelial carcinomas: state of the art for the yearly scientific report of the French National Association of Urology - Varinot J, Colin P, Rouprêt M, Leroy X, Comperat E. Prog Urol.

2014
Non-surgical treatment modalities available for the treatment of upper tract urothelial carcinomas: state-of-the-art for the yearly scientific report of the French National Association of Urology - Audenet F, Rouprêt M, Houédé N, Colin P. Prog Urol.

2014
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy. - Hurel S, Rouprêt M, Seisen T, Comperat E, Phé V, Droupy S, Audenet F, Pignot G, Cathelineau X, Guy L, Cussenot O, Ouzzane A, Bozzini G, Nison L, Ruffion A, Colin P World J Urol.

2014
Imaging of urothelial carcinomas of the upper tract: state of the art for the yearly scientific report of the National French Association of Urology - Puech P, Rouprêt M, Renard-Penna R, Lemaître L, Colin P. Prog Urol.

2014
Epidemiology and risk factors of upper urinary tract tumors: literature review for the yearly scientific report of the French National Association of Urology - Ouzzane A, Rouprêt M, Leon P, Yates DR, Colin P. Prog Urol.

2014
Conservative management of urothelial carcinomas of the upper tract: systematic review for the yearly scientific report of the French National Association of Urology - Pignot G, Colin P, Rouprêt M, Traxer O. Prog Urol.

2014
Clinical, ureteroscopic and photodynamic diagnosis of urothelial carcinomas of the upper tract: state-of-the art for the yearly scientific report of the French National Association of Urology - Nison L, Bozzini G, Rouprêt M, Traxer O, Colin P. Prog Urol.

2014
Carcinogenic pathways and natural history of upper tract urothelial carcinomas: state-of-the-art for the yearly scientific report of the French National Association of Urology - Seisen T, Cancel-Tassin G, Colin P, Cussenot O, Rouprêt M. Prog Urol.

2014
Bladder cancer: Tumour recurrence after radical nephroureterectomy for UTUC - Ouzzane A, Colin P Nat Rev Urol.

2013
The outbreak of focal therapy for localized prostate cancer management - Bozzini G, Colin P, Betrouni N, Ouzzane A, Puech P, Villers A. Rev Prat

2013
The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy - Ouzzane A, Colin P, Ghoneim TP, Zerbib M, De La Taille A, Audenet F, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Maurin C, Nouhaud FX, Phe V, Polguer T, Roumiguié M, Ruffion A, Rouprêt M World J Urol

2013
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy. - Colin P, Ghoneim TP, Nison L, Seisen T, Lechevallier E, Cathelineau X, Ouzzane A, Zerbib M, Long JA, Ruffion A, Crouzet S, Cussenot O, Audouin M, Irani J, Gardic S, Gres P, Audenet F, Roumiguié M, Valeri A, Rouprêt M World J Urol

2013
Prognostic Value Of Microrna Expression Pattern In Upper Tract Urothelial Carcinoma - Izquierdo L, Ingelmo-Torres M, Mallofré C, Lozano JJ, Verhasselt-Crinquette M, Leroy X, Colin P, Comperat E, Roupret M, Alcaraz A, Mengual L. BJU Int

2013
Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study. - Neuzillet Y, Soulie M, Larre S, Roupret M, Defortescu G, Murez T, Pignot G, Descazeaud A, Patard JJ, Bigot P, Salomon L, Colin P, Rigaud J, Bastide C, Durand X, Valeri A, Kleinclauss F, Bruyere F, Pfister C BJU Int.

2013
Malnourishment in bladder cancer and the role for immunonutrition at the time of cystectomy: an overview for urologists - Munbauhal G, Drouin SJ, Mozer P, Colin P, Phé V, Cussenot O, Rouprêt M. BJU Int.

2013
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. - Pignot G, Colin P, Zerbib M, Audenet F, Soulié M, Hurel S, Delage F, Irani J, Descazeaud A, Droupy S, Rozet F, Phé V, Ruffion A, Long JA, Crouzet S, Houlgatte A, Bigot P, Guy L, Faïs PO, Rouprêt M Urol Oncol

2013
Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma - Masson-Lecomte A, Colin P, Bozzini G, Nison L, de La Taille A, Comperat E, Zerbib M, Rozet F, Cathelineau X, Valeri A, Ruffion A, Guy L, Droupy S, Cussenot O, Rouprêt M. World J Urol.

2013
Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy - Hurel S, Rouprêt M, Ouzzane A, Rozet F, Xylinas E, Zerbib M, Berod AA, Ruffion A, Adam E, Cussenot O, Houlgatte A, Phé V, Nouhaud FX, Bensadoun H, Delage F, Guillotreau J, Guy L, Karsenty G, De La Taille A, Colin P BJU Int.

2013
Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours. - Hollande C, Colin P, de La Motte Rouge T, Audenet F, Yates DR, Phé V, Ouzzane A, Droupy S, Ruffion A, de La Taille A, Guy L, Cussenot O, Rozet F, Xylinas E, Zerbib M, Spano JP, Khayat D, Bitker MO, Rouprêt M BJU Int

2013
Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model. - Bozzini G, Colin P, Betrouni N, Maurage CA, Leroy X, Simonin S, Martin-Schmitt C, Villers A, Mordon S Photodiagnosis Photodyn Ther

2013
CCAFU Recommendations 2013: Upper urinary tract carcinoma - Pfister C, Roupret M, Neuzillet Y, Larré S, Pignot G, Quintens H, Houedé N, Compérat E, Colin P, Roy C, Davin JL, Guy L, Irani J, Lebret T, Coloby P, Soulié M; Les membres du CCAFU. Prog Urol

2013
CCAFU Recommendations 2013: Bladder carcinoma - Pfister C, Roupret M, Neuzillet Y, Larré S, Pignot G, Quintens H, Houedé N, Compérat E, Colin P, Roy C, Davin JL, Guy L, Irani J, Lebret T, Coloby P, Soulié M; Les membres du CCAFU. Prog Urol

2013
An image guided treatment platform for prostate cancer photodynamic therapy. - Betrouni N, Colin P, Puech P, Villers A, Mordon S. Conf Proc IEEE Eng Med Biol Soc.

2013
An anatomically realistic and adaptable prostate phantom for laser thermotherapy treatment planning - Betrouni N, Nevoux P, Leroux B, Colin P, Puech P, Mordon S. Med Phys.

2013
A New Proposal to Risk Stratify Urothelial Carcinomas of the Upper Urinary Tract (UTUCs) in a Predefinitive Treatment Setting: Low-risk Versus High-risk UTUCs - Rouprêt M, Colin P, Yates DR. Eur Urol.

2012
Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasm - Rouprêt M, Colin P World J Urol

2012
The role of ASA scores in predicting UUT-UC outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study - Arvin-Berod A, Colin P, Yates DR, Ouzzane A, Audouin M, Adam E, Arroua F, Marchand M, Bigot P, Soulié M, Roumiguié M, Polguer T, Gardic S, Grès P, Ravier E, Neuzillet Y, Delage F, Bodin T, Pignot G, Rouprêt M BJU Int

2012
The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database - Nison L, Rouprêt M, Bozzini G, Ouzzane A, Audenet F, Pignot G, Ruffion A, Cornu JN, Hurel S, Valeri A, Roumiguie M, Polguer T, Hoarau N, Mérigot de Treigny O, Xylinas E, Matte A, Droupy S, Fais PO, Descazeaud A, Colin P World J Urol

2012
Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI - Sufana Iancu A, Colin P, Puech P, Villers A, Ouzzane A, Fantoni JC, Leroy X, Lemaitre L World J Urol

2012
Rôle pronostique des emboles vasculaires tumoraux dans les tumeurs de la voies excrétrices urinaires supérieures: analyse rétrospective monocentrique - Colin P, Verhasselt-Crinquette M, Ouzzane A, Yakoubi R, Bouchery C, Debrock S, A Villers, Leroy X Prog Urol.

2012
Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized post-operative nomogram using decision curve analysis. - Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, et al. J Urol

2012
Photodynamic Therapy in urology: what can we do now and where are we heading? - Bozzini G, Colin P, Betrouni N, Nevoux P, Ouzzane A, Puech P, Villers A, Mordon S Photodiagnosis Photodyn. Ther.,

2012
Oncologic Outcomes and Survival in pT0 Tumors After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results from of a Large Multicenter International Collaborative Study - Rouprêt M, Xylinas E, Colin P, Kluth L, Karakiewicz P, Shariat SF Eur Urol

2012
Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. - Xylinas E, Colin P, Audenet F, Phe V, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyère F, Polguer T, Ruffion A, Valeri A, Rozet F, Long JA, Zerbib M, Rouprêt M. World J Urol

2012
Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort - Bozzini G, Nison L, Colin P, Ouzzane A, Yates DR, Audenet F, Pignot G, Arvin-Berod A, Merigot O, Guy L, Irani J, Saint F, Gardic S, Gres P, Rozet F, Neuzillet Y, Ruffion A, Roupret M World J Urol

2012
Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival - Colin P, Ouzzane A, Yates DR, Audenet F, Pignot G, Arvin-Berod A, Merigot de Treigny O, Valeri A, Irani J, Saint F, Gardic S, Gres P, Rozet F, Neuzillet Y, Ruffion A, Rouprêt M Ann Surg Oncol

2012
Focal therapy of prostate cancer: Energies and procedures - Bozzini G, Colin P, Nevoux P, Villers A, Mordon S, Betrouni N Urol Oncol

2012
Focal Laser Ablation of Prostate Cancer: Definition, Needs and Future - Colin P, Mordon S, Nevoux P, Marqa MF, Ouzzane A, Puech P, Bozzini G, Leroux B,Villers A, Betrouni N Adv Urol.

2012
Elastic image registration for guiding focal laser ablation of prostate cancer: Preliminary results - Makni N, Puech P, Colin P, Azzouzi A, Mordon S, Betrouni N Comput. Methods Programs Biomed

2012
Conservative Management of Upper Tract Urothelial Carcinoma in France: A 2004-2011 National Practice Report - Colin P, Rouprêt M, Ghoneim TP, Traxer O, Zerbib M, Xylinas E Eur Urol

2012
Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. - Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M BJU Int

2012
Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram - Yates DR, Hupertan V, Colin P, Ouzzane A, Descazeaud A, Long JA, Pignot G, Crouzet S, Rozet F, Neuzillet Y, Soulie M, Bodin T, Valeri A, Cussenot O, Rouprêt M Br J Cancer

2012
Assessment of Human Epidermal Growth Factor Receptor 2 status in urothelial carcinoma of the upper urinary tract. A study using dual-colour in-situ hybridization and immunohistochemistry - Verhasselt-Crinquette M, Colin P, Ouzzane A, Gnemmi V, Robin YM, Aubert S, Villers A, Leroy X Applied Immunohistochemistry & Molecular Morphology

2012
A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool - Audenet F, Colin P, Yates DR, Ouzzane A, Pignot G, Long JA, Soulie M, Phé V, Bensadoun H, Guy L, Ruffion A, Valeri A, Cormier L, Droupy S, De La Taille A, Saint F, Faïs PO, Houlgatte A, Cussenot O, Rouprêt M BJU Int.